Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure — Stella

Home/Developmental Delay/

View on ClinicalTrials.gov

Recruiting

Back to Developmental Delay trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

United States

University of New Mexico Health Sciences Center, Albuquerque, New Mexico

Avera Research Institute, Sioux Falls, South Dakota

University of Vermont Medical Center, Burlington, Vermont

Key details

Sponsor

IDeA States Pediatric Clinical Trials Network

Collaborators

University of New Mexico, University of Vermont

Enrollment target

~20 participants

Started

February 2025

Primary completion

June 2026

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.